ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2449

Acid Reflux Triggers Type I Interferon and Persistent Epithelial-mesenchymal Transition in Esophageal Epithelial Cells. a Novel Microenvironment Contribution to the Pathogenesis of Systemic Sclerosis

Safoura Zahed Mohajerani1, john ladbury1, Rebecca Ross2 and Francesco Del Galdo1, 1University of Leeds, Leeds, United Kingdom, 2Medicine and Health, University of Leeds, Leeds, United Kingdom

Meeting: ACR Convergence 2024

Keywords: Fibroblasts, Dermal, Scleroderma, Systemic

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Gastroesophageal reflux disease (GERD) is a very common manifestation of scleroderma (SSc), affecting as high as 90% of patients, second only to Raynaud’s phenomenon. GERD is also a very common in the general population, not dissimilarly from Raynaud’s phenomenon. The acid induced injury and repair of the distal esophageal mucosa is known to be a risk factor for metaplastic transformation of the epithelium (Barret esophagus) and in turn, increases the risk of esophageal cancer. Nonetheless, it is not known whether the cellular and molecular events induced by acid injury may have a role in the loss of immunological tolerance and/or other aspects of the pathogenesis of SSc. Here we aimed to study the morphological and molecular changes induced by acid exposure of esophageal cells to inform research on their role in the pathogenesis of SSc.

Methods: Normal squamous epithelial cells (Het1A) were exposed to acidified media (pH 4) contains 100μM bile salts for 10 minutes/day for five consecutive days. Media was acidified through the addition of 1M hydrochloric acid. Bile salts mix comprised glychocolic acid, taurocholic acid, glycodeoxycholic acid, glycochenodeoxycholic acid and deoxycholic acid. After 5 days of bile acid (BA) exposure cells grown in full media until day 21 to access their recovery from BA. Co-culture of healthy and SSc derived fibroblasts and Het1A cells was performed by Transwell assays and exposed to BA as described above. Twenty-four hours after the last treatment Het1A cells were lysed for protein and RNA analyses.

Results: Oesophageal epithelial cells exposed to acid lost their cobblestone appearance and acquired mesenchymal characteristics (change in orthogonal diameters ratio P< 0.0001). Further, cells lost the usual cell-cell junction. These changes were confirmed by qPCR and immunofluorescence which showed increased expression of EMT markers vimentin (p=0.001) and N-cadherin (p=0.05). Transcriptome analysis identified 3313 genes differentially expressed in the cells after chronic BA exposure (p< 0.05, t test). GO pathway analysis indicated upregulation of response to interferons, type I interferon signalling pathway, response to interleukin-1, compared with the control. qRT-PCR confirmed significant increased expression of STAT1 (p< 0.0001), OAS1 (p=0.0004), ISG15 (p=0.002) and IFIT1 (p< 0.0001). Co-culture of epithelial cells with SSc fibroblasts enhanced these changes with significant upregulation of both type I IFN and EMT genes compared to heatlhy fibroblasts. Following 16 days of further culture from last BA insult, showed normalisation of Type I IFN response vs persistent and enhanced EMT including increased expression of vimentin (p=0.001) and N-cadherin (p=0.0004).

Conclusion: Challenge with BA has a direct effect on the morphology and transcriptome of esophageal epithelial cells including proinflammatory and profibrotic gene expression. Co-culture with SSc fibroblasts enhances this response suggesting that as well in the context of a permissive genetic background, a common condition such as acid reflux may contribute to the pathogenesis of SSc.


Disclosures: S. Zahed Mohajerani: None; j. ladbury: None; R. Ross: Deepcure, 5; F. Del Galdo: AbbVie, 2, 5, Argenx, 2, Arxx, 2, 5, AstraZeneca, 2, 5, Boehringer Ingelheim, 2, 5, Chemomab, 5, Deepcure, 2, GlaxoSmithKline (GSK), 2, Janssen, 2, Mitsubishi Tanabe, 5, Novartis, 2, Ventus, 2.

To cite this abstract in AMA style:

Zahed Mohajerani S, ladbury j, Ross R, Del Galdo F. Acid Reflux Triggers Type I Interferon and Persistent Epithelial-mesenchymal Transition in Esophageal Epithelial Cells. a Novel Microenvironment Contribution to the Pathogenesis of Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/acid-reflux-triggers-type-i-interferon-and-persistent-epithelial-mesenchymal-transition-in-esophageal-epithelial-cells-a-novel-microenvironment-contribution-to-the-pathogenesis-of-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/acid-reflux-triggers-type-i-interferon-and-persistent-epithelial-mesenchymal-transition-in-esophageal-epithelial-cells-a-novel-microenvironment-contribution-to-the-pathogenesis-of-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology